Creating a patient and community advisory committee at the Canadian Agency for Drugs and Technologies in Health

被引：5

作者：

Berglas, Sarah ^{[1
]}

Vautour, Nadine ^{[1
]}

Bell, Daryl ^{[1
]}

机构：

[1] Canadian Agcy Drugs & Technol Hlth CADTH, 865 Carling Ave, Ottawa, ON K1S 5S8, Canada

来源：

INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE | 2021年 / 37卷 / 01期

关键词：

Patient participation; Community participation; Technology assessment;

D O I：

10.1017/S0266462320002251

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

In recognition of patients' roles using, and contributing to, a publicly funded health system, the Canadian Agency for Drugs and Technologies in Health (CADTH) created a Patient and Community Advisory Committee. Twelve members bring lived experiences of chronic illness, progressive illness, mental illness, trauma, traveling long distances for treatment, and caregiving to an ill child, parent, or spouse. Members contribute their own insights and ideas but do not represent specific organizations or viewpoints. This paper explores how CADTH determined the committee's role, whether to have individuals or organizations as members, and how to recruit for diversity. The creation of this committee is changing how CADTH engages with patients.

引用

页数：4